Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India · Delayed Price · Currency is INR 2,393.70
-12.60 (-0.52%)
May 4, 2026, 3:30 PM IST
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 679.06 billion as of May 4, 2026. Its market cap has increased by 67.02% in one year.
Market Cap
679.06B
Enterprise Value
664.40B
Revenue
165.10B
Ranking
n/a
PE Ratio
63.76
Stock Price
2,393.70
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 679.06B, an increase of 58,984.48%. That is a compound annual growth rate of 29.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 679.06B | 18.23% |
| Dec 31, 2025 | 574.34B | 26.49% |
| Dec 31, 2024 | 454.07B | 88.44% |
| Dec 29, 2023 | 240.96B | 101.33% |
| Dec 30, 2022 | 119.68B | -19.75% |
| Dec 31, 2021 | 149.14B | 7.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.73T |
| Cipla | 1.06T |
| Mankind Pharma | 927.50B |
| Zydus Lifesciences | 897.46B |
| Aurobindo Pharma | 807.02B |
| Alkem Laboratories | 645.65B |
| Laurus Labs | 594.36B |
| Ipca Laboratories | 388.40B |